Ovintiv Sets Record Date for 2026 Annual Meeting
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ovintiv ( (OVV) ) has provided an announcement.
Ovintiv Inc. has scheduled its 2026 annual meeting of stockholders for May 6, 2026, and set March 9, 2026 as the record date for determining holders of its common stock entitled to receive notice of and vote at the meeting. The company has notified Canadian securities regulators and both the Toronto and New York stock exchanges of these arrangements, and outlined that it will use notice-and-access provisions for both registered and beneficial holders while agreeing to pay for delivery of proxy-related materials to objecting beneficial owners, clarifying the mechanics of shareholder participation and voting ahead of the meeting.
The most recent analyst rating on (OVV) stock is a Hold with a $44.00 price target. To see the full list of analyst forecasts on Ovintiv stock, see the OVV Stock Forecast page.
Spark’s Take on OVV Stock
According to Spark, TipRanks’ AI Analyst, OVV is a Neutral.
The score is driven primarily by mixed financial performance (pressure on revenue and free cash flow despite solid margins and a stable balance sheet). Technicals are supportive with strong trend/momentum, and the earnings call was broadly positive on guidance and the NuVista deal, but valuation is a notable headwind due to a high P/E.
To see Spark’s full report on OVV stock, click here.
More about Ovintiv
Ovintiv Inc. is a publicly listed corporation whose common stock trades on both the Toronto Stock Exchange and the New York Stock Exchange, indicating its presence in North American capital markets and an investor base spanning Canadian and U.S. shareholders.
Average Trading Volume: 3,660,261
Technical Sentiment Signal: Strong Buy
Current Market Cap: $10.83B
Find detailed analytics on OVV stock on TipRanks’ Stock Analysis page.
